The Complete Guide to Tinnitus Treatments

What Tinnitus Treatment Actually Means: What This Guide Covers

There is no cure for tinnitus, but cognitive behavioural therapy (CBT) has the strongest evidence base of any treatment available. A Cochrane review of 28 randomised controlled trials found it reduces tinnitus-related quality-of-life impact by a clinically meaningful margin, and it is recommended as first-line treatment for persistent, bothersome tinnitus by both US and German clinical guidelines (Fuller et al., 2020).

If you found this page, you are probably hoping to make the ringing stop. That hope is completely understandable, and you deserve a straight answer: no treatment currently reliably eliminates the sound itself in most people. What treatment can do is change how much the sound disrupts your life, and for many people, that difference is enormous.

“Learn to live with it” is advice that healthcare providers still give far too often, and without follow-up treatment options, it can leave patients feeling abandoned at exactly the moment they most need support (Kleinjung et al., 2024). This guide is not going to do that.

Instead, you will find a tiered, evidence-graded roadmap of tinnitus treatment options. Some treatments have Cochrane-level evidence from dozens of randomised trials. Others are widely used but supported by more limited data. A few are still investigational. You will also find a clear list of what the evidence says does not work, because time and money spent on ineffective options delays access to what does.

“Treatment” for tinnitus covers two distinct goals: reducing the distress tinnitus causes (fear, anxiety, sleep disruption, concentration problems) and managing the comorbidities that tinnitus worsens. Different interventions target each. Understanding that distinction is the foundation for everything that follows.

Before Any Tinnitus Treatment: Getting the Right Diagnosis

Choosing the right treatment depends on knowing what you are treating. Tinnitus is not a single condition; it is a symptom with multiple possible causes and contributing factors. Before any treatment pathway is considered, an audiological assessment is the essential first step.

The 2014 AAO-HNS (American Academy of Otolaryngology–Head and Neck Surgery) Clinical Practice Guideline (Tunkel et al.) recommends audiological testing for anyone with tinnitus accompanied by hearing difficulty, unilateral tinnitus (sound in only one ear), or tinnitus that persists. The 2024 VA/DoD Clinical Practice Guideline reinforces this, noting that tinnitus affects quality of life in a meaningful way for approximately 20% of those who experience it, and that accurate characterisation of the tinnitus guides treatment selection.

The bothersome/non-bothersome distinction matters. The AAO-HNS guideline identifies “bothersome tinnitus” as the key threshold for active treatment. Non-bothersome tinnitus (perceived but not causing distress, sleep problems, or concentration difficulties) typically warrants reassurance and monitoring rather than intensive intervention. If tinnitus is affecting your sleep, mood, concentration, or relationships, that is the clinical signal that active treatment is warranted.

Duration also shapes the clinical response. Acute tinnitus (onset within weeks) requires prompt attention to rule out treatable medical causes: sudden sensorineural hearing loss, ear infection, medication side effects, or vascular causes. Pulsatile tinnitus (a rhythmic sound that beats in time with your pulse) and unilateral tinnitus both warrant prompt referral to an ENT specialist, as both can signal underlying conditions that need investigation.

Chronic tinnitus, typically defined as lasting more than three to six months, shifts the clinical focus. At that point, the auditory system has had time to establish its response patterns, and the primary treatment target becomes distress management and quality-of-life improvement rather than eliminating the underlying cause.

An audiological assessment will typically measure your hearing thresholds across frequencies, characterise the tinnitus (pitch, loudness, masking level), and identify whether hearing loss is present. That last finding shapes everything: the American Tinnitus Association estimates that roughly 90% of people with chronic tinnitus have some degree of hearing loss, a figure consistent with clinical experience though drawn from clinician survey data rather than a controlled epidemiological study (American Tinnitus Association, 2024), and treatment pathways diverge significantly based on whether amplification is indicated.

If your tinnitus started suddenly, is only in one ear, is pulsatile, or is accompanied by sudden hearing loss or dizziness, see your doctor promptly. These patterns can indicate conditions that need urgent assessment.

The Evidence Hierarchy: How to Read Tinnitus Treatment Claims

Tinnitus treatment research uses a tiered evidence system, and understanding it helps you evaluate claims you will encounter from clinics, websites, and supplement companies.

This guide uses a three-tier framework aligned with the grading systems used by the AAO-HNS, VA/DoD, and NICE (National Institute for Health and Care Excellence) guidelines:

One honest caveat about tinnitus research: blinding is genuinely difficult. You cannot easily create a placebo hearing aid or a fake CBT session that is convincing enough to deceive participants. This means effect sizes in tinnitus trials may include some placebo contribution, and it is one reason why even the best-evidenced treatments carry GRADE (Grading of Recommendations, Assessment, Development and Evaluation) ratings of “moderate” rather than “high.” This does not mean the treatments do not work. It means the evidence has been earned in genuinely challenging conditions, and the treatments that have cleared that bar deserve attention.

The umbrella review by Chen et al. (2025), which synthesised 44 systematic reviews covering all major treatment categories through April 2025, confirms that CBT, hearing aids, TRT, and sound therapy all consistently improve tinnitus-related outcomes across the available evidence base. The tiers below reflect the strength of that evidence, not arbitrary rankings.

Tier 1: Cognitive Behavioural Therapy (CBT) for Tinnitus: The Strongest Evidence

CBT has more high-quality evidence behind it than any other tinnitus treatment. If you take one thing from this guide, let it be this: CBT is not a last resort when nothing else has worked. It is where the evidence says treatment should start.

What CBT for tinnitus involves

CBT for tinnitus is a structured psychological treatment, typically delivered over 6 to 12 weeks, that addresses the thoughts, behaviours, and emotional responses that turn a sound into a crisis. It usually includes psychoeducation about how tinnitus works (and why the brain amplifies it), cognitive restructuring to challenge unhelpful beliefs about the sound, relaxation training, and attention-shifting techniques that reduce the brain’s focus on the signal.

It is not about pretending tinnitus does not exist or simply thinking positively. The underlying mechanism is habituation: as the brain learns that the signal does not predict danger or harm, it gradually reduces the priority it assigns to it. CBT provides the structured framework for that learning process.

What the Cochrane evidence shows

The Fuller et al. (2020) Cochrane review analysed 28 randomised controlled trials involving 2,733 participants. Comparing CBT against a waitlist control (14 studies), the pooled effect was a 10.91-point improvement on the Tinnitus Handicap Inventory (THI). The MCID (minimum clinically important difference) for the THI is 7 points. CBT exceeds that threshold, meaning the improvement is not just statistically detectable but genuinely meaningful in patients’ daily lives.

Compared with audiological care alone (3 studies, 444 participants), CBT produced a 5.65-point additional improvement on the THI. When CBT was compared against other active treatments across 16 studies, the pooled effect was 5.84 THI points, below the 7-point MCID, suggesting the advantage over other active interventions is more modest than the advantage over doing nothing. No serious adverse effects were reported across any of the trials.

The expectation that matters most

CBT does not reduce tinnitus loudness. The sound, measured in decibels, does not get quieter. This finding from the Fuller et al. (2020) Cochrane review surprises many patients, and it is worth being explicit about it before starting treatment. CBT changes your response to the sound, not the sound itself. For most people in the trials, that was enough to substantially reduce distress, improve sleep, and allow them to function normally despite still hearing the tinnitus.

If you are looking specifically for a treatment that silences tinnitus, CBT will not deliver that. If you are looking for a treatment that meaningfully reduces how much tinnitus disrupts your life, the evidence is clear.

Online and app-based CBT: a real option

The Xian et al. (2025) meta-analysis of 9 randomised controlled trials confirmed that internet-based and mobile CBT significantly improves tinnitus distress (Tinnitus Functional Index improvement: MD -12.48 points), insomnia, anxiety, and depression compared with control conditions. One nuance: in this analysis, improvement on the THI specifically did not reach statistical significance (MD -2.98, p=NS), while improvements on the TFI (Tinnitus Functional Index) and symptom measures were large and significant. Face-to-face CBT clears the THI MCID threshold in the Cochrane review; internet CBT may not on that specific scale, but it clearly improves the wider burden of tinnitus.

The NICE NG155 guideline (2020) positions digital CBT as the recommended Step 1 (first-line) treatment for tinnitus-related distress, before group or individual face-to-face therapy. This matters practically: waitlists for in-person psychological therapy can be long, and validated online programmes are accessible immediately. If you have been told CBT is not available in your area, asking specifically about digital CBT pathways is worth doing.

CBT has the strongest evidence base of any tinnitus treatment, with a Cochrane review of 28 RCTs showing clinically meaningful reduction in tinnitus distress. It does not reduce loudness. Both face-to-face and online delivery are effective, and NICE recommends digital CBT as first-line treatment.

Tier 1: Hearing Aids for Tinnitus: First Line When Hearing Loss Is Present

For anyone with tinnitus and measurable hearing loss, hearing aids are a front-line intervention. This is not a consolation prize. Amplification addresses one of the main drivers of tinnitus perception, and the guidelines are clear.

Why hearing loss and tinnitus are linked

The large majority of people with chronic tinnitus also have some degree of hearing loss: the American Tinnitus Association estimates this figure at approximately 90%, based on clinician survey data (American Tinnitus Association, 2024). The connection is not coincidental. When the auditory system receives reduced input from the cochlea (the fluid-filled inner ear structure responsible for converting sound into nerve signals), the brain compensates by turning up its internal gain. That amplified internal signal is, in many cases, what becomes tinnitus.

Hearing aids work for tinnitus through several overlapping mechanisms: they amplify external environmental sound, which provides partial masking of the tinnitus; they re-stimulate auditory pathways that have been deprived of input; and they reduce the frustration and cognitive effort of strained listening, which itself contributes to tinnitus-related distress.

What outcomes to expect

The evidence base for pure hearing aid amplification in tinnitus is primarily guideline-level rather than Cochrane-level (the Sereda et al. (2018) Cochrane review covers sound generators and combination devices, not amplification alone). Clinician survey data from the ATA (American Tinnitus Association, 2024) indicates that roughly 60% of tinnitus patients get at least some relief from hearing aids, and approximately 22% experience significant relief. Outcomes vary, and a hearing aid does not predictably silence tinnitus. What it reliably does, in many patients, is reduce the contrast between the tinnitus and the ambient sound environment, which reduces the signal’s salience.

Combination devices (a hearing aid with a built-in sound generator) are also available and may suit patients who want both amplification and a continuous low-level noise background. The Sereda et al. (2018) Cochrane review found no significant additional benefit of combination devices over standard hearing aids alone in the limited trials available, but both showed clinically meaningful within-group improvements.

Guideline support

The AAO-HNS Clinical Practice Guideline gives a strong recommendation for a hearing aid evaluation in patients with bothersome tinnitus and documented hearing loss. The VA/DoD 2024 guideline and NICE NG155 both support hearing amplification for tinnitus with hearing loss affecting communication.

“I’d been told my hearing loss was ‘mild’ and didn’t need addressing. It wasn’t until a tinnitus audiologist fitted hearing aids that I realised how much cognitive effort I was spending straining to hear, and how much that was feeding the tinnitus. Within a few months of wearing them consistently, the intrusive quality faded significantly.”

This patient account reflects a common clinical pattern; individual outcomes vary.

If hearing aids have been recommended to you and you have been putting off getting them, this is the clinical case for acting. Hearing aids combined with counselling consistently produce better outcomes than hearing aids alone (Chen et al., 2025).

Tier 2: Sound Therapy for Tinnitus: Helpful, but Best Combined With Counselling

Sound therapy covers a wide range of tools: tabletop white noise machines, smartphone apps, wearable noise generators, and specialised approaches like notched music. These tools are widely used, low-risk, and genuinely useful for many people. They are also widely misunderstood.

How sound therapy works

Sound therapy works by reducing the perceptual contrast between tinnitus and background sound. When the acoustic environment is very quiet (a bedroom at 2 a.m., for example), tinnitus tends to be most intrusive because the brain has almost nothing else to process. A steady, unobtrusive sound source reduces that contrast and can make it easier to shift attention away from the tinnitus signal.

The proposed mechanisms include partial masking (covering the tinnitus), habituation facilitation (providing a neutral sound that the brain learns to filter out, which may support filtering of tinnitus by association), and reduced auditory contrast that may, over time, reduce central gain (the brain’s tendency to amplify internal signals when external input is reduced).

What the Cochrane evidence says

The Sereda et al. (2018) Cochrane review (8 RCTs, n=590) found no evidence that sound therapy devices are superior to placebo or waiting list as standalone treatments. Head-to-head comparisons of combination devices versus hearing aids alone showed no significant difference (standardised mean difference: -0.15). Both device types were associated with clinically meaningful within-group THI reductions, but these within-group improvements cannot be cleanly separated from natural tinnitus fluctuation or placebo effects in the absence of a properly controlled comparator.

This is an important distinction. Sound therapy does not have the same evidence base as CBT. That does not mean it does not help people: it means the controlled evidence for it standing alone is limited. The Cochrane authors concluded the evidence was insufficient to determine whether sound therapy is beneficial or harmful compared with waiting list or placebo.

The critical multiplier: counselling

The picture changes significantly when sound therapy is combined with structured counselling or education. A network meta-analysis by Liu et al. (2021) found that combination sound therapy plus educational consultation yielded significantly better outcomes than sound therapy alone. The counselling component appears to be what activates the benefits of sound therapy by providing a cognitive framework for habituation.

This finding has direct practical implications. Using a white noise app on its own, without any structured support or psychoeducation, is substantially less likely to help than the same sound therapy delivered as part of a supported programme.

Tier 2: Tinnitus Retraining Therapy (TRT): Structured Habituation

TRT is one of the best-known tinnitus treatments, and it occupies an interesting position in the evidence hierarchy: it clearly works in the sense that most people who complete a TRT programme improve, but the evidence for it working better than other active approaches is limited.

The model behind TRT

TRT was developed by Pawel Jastreboff based on a neurophysiological model: tinnitus distress arises not from the sound itself but from conditioned responses in the limbic system (the brain’s emotional processing network) and autonomic nervous system. The tinnitus signal, in this model, has been tagged by the brain as important and threatening, which is why it is hard to ignore. TRT aims to reclassify the signal as neutral through a combination of directive counselling (explaining the model and reframing how patients understand their tinnitus) and broadband sound enrichment (reducing the contrast between the tinnitus and the acoustic environment). The programme typically runs 12 to 18 months.

What the evidence shows

The Bauer et al. (2017) 18-month controlled trial compared TRT (directive counselling plus combination hearing aids/sound generators) against standard audiological care in patients with chronic bothersome tinnitus and hearing loss. Both groups improved significantly on the THI and TFI; TRT showed a larger treatment effect. This is a meaningful finding, but the trial used an active versus active comparator with no placebo arm, which limits the conclusions that can be drawn.

The most current systematic review, Alashram (2025), covering 15 RCTs and 2,069 patients, found that TRT did not provide superior outcomes compared with tinnitus masking, educational counselling, partial TRT, tailor-made notched music training, or usual care. TRT is effective, but it does not stand clearly above other well-delivered active treatments.

The AAO-HNS guideline rates TRT’s evidence quality as very low. NICE NG155 could not make a recommendation for TRT, citing variability in delivery and insufficient evidence. The German AWMF S3 guideline (the highest evidence-level tier in the German medical guideline system) takes a specific position: the directive counselling component of TRT appears to be the active ingredient, while the sound enrichment component adds no demonstrable benefit over counselling alone.

When TRT might suit you better than CBT

TRT uses an educational and auditory framing rather than a psychological one. For patients who find the psychological language of CBT off-putting, or who respond better to understanding tinnitus through an auditory/neurophysiological model, TRT may be a more acceptable starting point. Both approaches share a core mechanism (habituation) and both involve structured counselling. If you have tried CBT and found it insufficient after a full programme, TRT or a multimodal programme combining elements of both is a reasonable next step.

Tier 3: Emerging Treatments: Not Yet Ready for Routine Use

Several approaches are generating genuine interest in tinnitus research, with early trial data that is encouraging enough to follow closely. None are recommended for routine clinical use by current guidelines. This section explains what they are, what the evidence shows, and what “watch this space” means in practice.

Bimodal neuromodulation (Lenire)

Bimodal neuromodulation combines auditory input (sound delivered through headphones) with simultaneous mild electrical stimulation to the tongue. The theory is that activating two sensory pathways at once can drive neuroplastic (brain-rewiring) changes in auditory cortex (the brain region that processes sound) processing of the tinnitus signal.

Conlon et al. (2020) conducted a large, randomised, double-blinded exploratory study enrolling 326 adults with chronic subjective tinnitus. Both primary endpoints (THI and TFI) showed statistically significant reductions, with outcomes sustained over a 12-month post-treatment follow-up phase. Conlon et al. (2022) confirmed the findings in a second large RCT, with effect sizes ranging from moderate to large (Cohen’s d, a measure of effect size where values above 0.5 are considered large: -0.7 to -1.4), and 70.3% of participants reporting benefit. The 2022 study confirmed that sound alone without the tongue stimulation component was insufficient: the touch-based (somatosensory) element is the active component.

The Lenire device holds CE mark approval in Europe and has received FDA Breakthrough Device designation, an expedited review pathway, but has not received full FDA approval as a standard tinnitus treatment. NICE found insufficient evidence to make a recommendation, and it is not currently recommended as standard care by any major guideline. For now, it sits firmly in the investigational category: the trial data is noteworthy, but larger and longer comparative trials are needed before it can be positioned alongside CBT or hearing aids.

Notched music therapy

Notched music therapy (NMT) works on the principle of cortical reorganisation: music with the frequency band around the tinnitus pitch removed (notched) is delivered, with the hypothesis that this selectively reduces neural activity at that frequency. A 2025 meta-analysis by Wen et al. (14 RCTs, n=793) found that NMT outperformed conventional music therapy on the THI (MD -8.62 points) and on a visual analogue scale for loudness at three months. That THI improvement clears the 7-point MCID.

One important limitation: the comparator in all these trials was conventional music therapy, not placebo or waitlist control. There is no large placebo-controlled Cochrane-level trial of NMT yet, and the VA/DoD 2024 guideline found insufficient evidence to recommend for or against it. The improvement over an active comparator is meaningful, but how much of the benefit is specific to the notching versus the general effect of structured music listening is not yet established.

Brain stimulation (TMS, tDCS)

Repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) aim to modulate activity in the auditory cortex or related brain areas associated with tinnitus perception. The AAO-HNS Clinical Practice Guideline explicitly recommends against rTMS for tinnitus outside of a clinical trial context. Active research is ongoing in this area, and it is possible that more targeted protocols may show efficacy in specific patient subgroups. At this stage, these are research tools, not clinical ones.

Digital therapeutics and app-based platforms

The 2025 Xian et al. meta-analysis (9 RCTs) confirms that internet-based and mobile CBT meaningfully improves tinnitus distress, insomnia, anxiety, and depression. Digital tinnitus therapy platforms that deliver validated CBT protocols represent an access pathway that can reach patients who cannot access in-person care, not a lesser version of treatment. NICE NG155 positions digital CBT as the first step in the recommended care pathway.

The distinction to maintain here: validated digital CBT platforms with structured protocols and evidence behind them are not the same as wellness apps or sound therapy applications. The digital delivery of a clinically validated programme is one thing; a sleep sounds app is another.

Emerging treatments like bimodal neuromodulation and notched music therapy have early evidence worth watching. Brain stimulation approaches are not currently recommended outside research settings. Digital CBT is already validated and guideline-recommended as a first-line access route.

What Does Not Work: Treatments to Avoid

The search for tinnitus relief has created a large market for products and approaches that do not have meaningful evidence behind them. Some of these are actively discouraged by clinical guidelines. Understanding why can save you significant time, money, and frustration.

Supplements: ginkgo biloba, zinc, melatonin

Ginkgo biloba is one of the most commonly tried supplements for tinnitus. The evidence against it is, by now, comprehensive. Sereda et al. (2022) conducted a Cochrane review of 12 RCTs involving 1,915 participants. Pooled analysis found no significant difference between ginkgo biloba and placebo on the THI (MD -1.35, 95% CI -8.26 to 5.55). There was no significant difference in tinnitus loudness, and no meaningful difference in quality of life. The evidence certainty was very low throughout. The AAO-HNS Clinical Practice Guideline carries a strong recommendation against treating tinnitus with ginkgo biloba, along with strong recommendations against zinc and other supplements.

Zinc supplements carry a risk of toxicity with long-term high-dose use and should not be used by people with kidney disease without medical supervision. Talk to your doctor before taking zinc supplements.

Melatonin is a separate case worth noting. Melatonin may genuinely help with the sleep disturbance that tinnitus causes, but it does not treat tinnitus itself. If sleep is your primary problem, melatonin may be worth discussing with your doctor for that specific indication. It will not reduce tinnitus loudness or distress. Note that melatonin can interact with sedative medications and should be used with caution during pregnancy; talk to your doctor before trying it, especially if you take any sedatives or sleep medications.

If you have tried ginkgo or zinc and felt they helped: placebo responses are real, they produce measurable changes in subjective experience, and that experience is not invalid. The Cochrane evidence tells us that at the population level, these supplements do not outperform inert pills. That is the information you need to make an informed decision about whether to continue spending money on them.

The AAO-HNS Clinical Practice Guideline carries strong recommendations against ginkgo biloba, zinc, melatonin (for tinnitus itself), anticonvulsants, benzodiazepines, and antidepressants as treatments for tinnitus. None of these should be taken without discussing the risks and rationale with your doctor. Ginkgo biloba in particular has a documented interaction with anticoagulants (blood thinners) that increases bleeding risk. Zinc supplements carry a risk of toxicity with long-term high-dose use and should not be used by people with kidney disease without medical supervision. Melatonin can interact with sedative medications and should be used with caution during pregnancy.

Anticonvulsants and sedatives

Gabapentin, carbamazepine, and benzodiazepines have all been evaluated for tinnitus. The AAO-HNS guideline recommends against anticonvulsants for tinnitus. Benzodiazepines are also not recommended: while they may temporarily reduce anxiety (which can be a tinnitus driver), they carry significant risks of dependence and do not address tinnitus directly. The VA/DoD 2024 guideline is explicit that no medication currently approved in the US is a proven treatment for tinnitus.

Intratympanic steroids for chronic tinnitus

Intratympanic steroids (injections into the middle ear) are used for certain inner ear conditions, including sudden sensorineural hearing loss. For chronic tinnitus specifically, the evidence does not support their use. The AAO-HNS guideline recommends against intratympanic medications for chronic tinnitus.

Acupuncture

The evidence on acupuncture for tinnitus is insufficient to draw conclusions in either direction. The AAO-HNS makes no recommendation (for or against), citing insufficient evidence. This is a different situation from ginkgo biloba, where Cochrane-level null results exist. With acupuncture, the absence of a recommendation reflects a lack of adequately powered trials, not established ineffectiveness. It remains an open question.

Building Your Tinnitus Management Plan: A Patient Decision Map

The evidence presented above points toward a practical sequence. If you have recently been diagnosed with tinnitus, or if you have been living with it without structured support, this is where to start.

Step 1: Get an audiological assessment. This is the non-negotiable first step. You need to know whether hearing loss is present, how the tinnitus is characterised, and whether any features (unilateral, pulsatile, sudden onset) warrant urgent referral. Without this, treatment selection is guesswork.

Step 2: If hearing loss is present, a hearing aid evaluation is the first clinical priority. Ask your audiologist or ENT for a formal evaluation. If the loss is mild and you have been told it does not need addressing, ask specifically about the tinnitus connection. The AAO-HNS guideline gives a strong recommendation here. Hearing aids combined with counselling produce better outcomes than either alone (Chen et al., 2025).

Step 3: If tinnitus is bothersome (affecting sleep, concentration, or mood), ask specifically about CBT referral. This is the treatment with the strongest evidence. If in-person CBT is not easily accessible, ask about validated digital CBT programmes. NICE NG155 recommends digital CBT as first-line specifically because it removes access barriers. Face-to-face CBT has slightly stronger trial evidence on the THI, but the Xian et al. (2025) meta-analysis confirms internet/mobile CBT significantly improves the broader burden of tinnitus.

Step 4: Use sound enrichment as a complementary tool. A sound generator, white noise app, or radio playing softly at night reduces the acoustic contrast that makes tinnitus more intrusive. Used alongside counselling or CBT, it is more effective than either alone (Liu et al., 2021). Used in isolation, the evidence for benefit over placebo is limited.

Step 5: If there is no meaningful improvement after three to six months, ask for specialist referral. A multidisciplinary tinnitus programme (audiologist and psychologist working together) or a structured TRT programme are the next steps. The evidence for specialist multidisciplinary care is strong: Chen et al. (2025) confirms this model consistently improves outcomes across systematic reviews. Asking for a structured tinnitus management programme at this stage is the right call.

Step 6: Be cautious about supplements, unproven devices, and expensive programmes without evidence. The AAO-HNS guidelines provide strong recommendations against ginkgo biloba, zinc, and various medications. The tinnitus supplement market is large and largely unregulated. Apply the evidence tier framework: ask what evidence exists, what comparator was used, and whether a guideline body has reviewed it.

The clearest starting point: audiological assessment, then hearing aid evaluation if hearing loss is present, then CBT (online or in-person) if tinnitus is bothersome. Sound therapy supports but does not replace structured treatment. TRT is a valid option, particularly for those who prefer an auditory model over a psychological one.

A note on multidisciplinary care: tinnitus that affects multiple life domains (sleep, mood, concentration, relationships) benefits from evidence-based tinnitus care that addresses all of them. An audiologist manages the hearing and sound aspects. A psychologist or CBT therapist addresses the distress response. When both work together, the evidence consistently shows better outcomes than either working alone (Chen et al., 2025; Kleinjung et al., 2024).

Conclusion: Tinnitus Is Treatable, Even When It Is Not Curable

No treatment currently available reliably eliminates tinnitus in most people. That is the honest answer, and it matters that you have it clearly.

What is also true is that the distress, the sleep disruption, the loss of concentration, the anxiety around every quiet room: all of that is genuinely treatable. CBT has a Cochrane review of 28 randomised trials behind it, with effect sizes that clear the threshold for clinical meaningfulness. Hearing aids make a measurable difference for the large majority of tinnitus patients who also have hearing loss. Sound therapy, delivered within a supported programme rather than in isolation, supports habituation over time. Emerging approaches are being tested in real trials, with real results (Conlon et al., 2020; Conlon et al., 2022).

Doing nothing is a choice. So is acting.

The first concrete step is an audiological assessment. At that appointment, ask about CBT referral (including digital options), and ask specifically about a hearing aid evaluation if you have any degree of hearing difficulty. Those two questions, asked of the right clinician, can open the door to treatments that have the evidence to genuinely help.